WHO ICTRP trial
Evaluation of the effect on Oral Administration of PAVANAK KATUKKAY along with…
CTRI/2024/02/063358 · Clinical Trials Registry India (CTRI) · Not Recruiting
Key facts
| Trial ID | CTRI/2024/02/063358 |
|---|---|
| Public title | Evaluation of the effect on Oral Administration of PAVANAK KATUKKAY along with THUMBAI NEI Nasiyam in the Management of NASIKAPEEDAM in Padiatric age group. |
| Scientific title | Preclinical and Clinical Evaluation of The Effect on Oral Administration of PAVANAK KATUKKAY along with THUMBAi NEI NASIYAM in the Management of NASIKAPEEDAM (NASAL POLYP) in Paediatric age group (5 TO 12 years). - NIL |
| Primary sponsor | DR K M ILACKIYAMATHI |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase 2 |
| Countries | India |
| Conditions | Health Condition 1: J33- Nasal polyp |
| Interventions | Intervention1: PAVANAK KATUKKAY (Internal Administration) Thumbai nei(Nasiyam): Internal medicine should be administrated orally twice a day after food intake.Dosage(according age of the patient) 500mg to 2gm.Duration 21 days. Nasiyam (1 to… |
| Registration date | Feb 29, 2024 |
| Target size | 40 |
| Secondary IDs | NIL |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: